Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer’s Disease
Crossref DOI link: https://doi.org/10.1007/s40266-016-0405-y
Published Online: 2016-09-28
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lefèvre, Gilbert
Callegari, Francesca
Gsteiger, Sandro
Xiong, Yuan
Funding for this research was provided by:
Novartis Pharma AG
License valid from 2016-09-28